VALIANT® Captivia VAMC3434C200TURecalls & reported problems
Medtronic, Inc. · STENT GRAFT VAMC3434C200TU VALCAP CLOSE · Class 3 · Implant
All models of VALIANT Captivia (95)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00643169346772), received between Sep 11, 2017 and Nov 6, 2019 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Activation, Positioning or Separation Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Activation, Positioning or Separation Problem1
- Leak/Splash1
Patient problems
- No Consequences Or Impact To Patient2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionNov 6, 2019Leak/Splash; Leak/Splash
A VALIANT CAPTIVIA STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A THORACIC AORTIC DISSECTION, EXTENDING THE ENTIRE LENGTH OF THE DESCENDING THORACIC AORTA. IT WAS REPORTED THAT DURING A FOLLOW-UP CT ON AN UNKNOWN DATE, IT WAS NOTED THAT THE PATIENT'S TYPE B DISSECTION WAS FILLING RETROGRADE, DUE TO A DISTAL FENESTRATION PRESSURIZING THE FALSE LUMEN AND INCREASING THE ANEURYSM SIZE. PER THE PHYSICIAN, THE CAUSE OF THE EVENT WAS RELATED TO THE PATIENT'S ANATOMY, DUE TO THE DISTAL FENESTRATION. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS BEING MONITORED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9283609 ↗MalfunctionSep 11, 2017Activation, Positioning or Separation Problem; Activation, Positioning or Separation Problem
A VALIANT CAPTIVIA STENT GRAFT SYSTEM WAS ATTEMPTED FOR USE IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 6.0 CM THORACIC AORTIC ANEURYSM. IT WAS NOTED THAT THE PATIENT HAD PREVIOUSLY HAD ANOTHER MANUFACTURER¿S THORACIC STENT GRAFT IMPLANTED AND HAD DEVELOPED AN ANEURYSM AT THE DISTAL END. IT WAS ALSO NOTED THAT THE PATIENT HAD VERY TORTUOUS ANATOMY. IT WAS REPORTED THAT THE VALIANT DEVICE WAS ADVANCED TO WITHIN THE OTHER MANUFACTURE¿S GRAFT. AS THE STENT GRAFT WAS DEPLOYED THE GRAFT COVER AND THE STENT GRAFT MOVED TOGETHER. IT BECAME DIFFICULT FOR THE PHYSICIAN TO CONTINUE TO UNSCREW THE STENT GRAFT SO THE DEVICE WAS REMOVED. WHEN THE DEVICE WAS MOVED DISTALLY INTO A STRAIGHTER PORTION OF THE ANATOMY, PART OF THE FABRIC CAME FORWARD FROM UNDER THE GRAFT COVER. A DIFFERENT VALIANT DEVICE WAS THEN INSERTED AND WAS DEPLOYED NORMALLY WHICH RESOLVED THE EVENT. THE PHYSICIAN STATED THAT THE EVENT WAS CAUSED BY VERY TORTUOUS ANATOMY. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS FINE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6854411 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page